Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial

Post time 2024-4-29 20:34:03

journal：International Clinical Psychopharmacology

Authors：Parnia Ebrahimi; Homa Seyedmirzaei; Kamyar Moradi; Sayna Bagheri; Mahdi Moeini; Mohammad-Reza Mohammadi; Shahin Akhondzadeh

Published date：2023-3-

DOI：10.1097/yic.0000000000000431

PDF link：https://journals.lww.com/10.1097/YIC.0000000000000431

Article link：http://dx.doi.org/10.1097/yic.0000000000000431

Article Source：Ovid Technologies (Wolters Kluwer Health)

Post time 2024-4-29 20:34:04

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Ovid] Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Ovid] Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial